| Time | Session |
|---|
|
09:20
09:45
|
Drugging transcription factors: HSF1 and Brachyury
|
|
09:45
09:55
|
Proffered Paper: Selected from Abstracts - to be announced in 2025
|
|
09:55
10:20
|
Targeting chromatin proteins for therapeutic benefit in haematological malignancy
|
|
10:20
10:30
|
Proffered Paper: Selected from Abstracts - to be announced in 2025
|
|
10:30
10:55
|
PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
|